Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
— Increased offer price to $3.65 per share, a $0.55 per share increase — Improved offer unanimously approved byRevance Board of Directors — Crown to extend tender offer until 11:59 p.m., Eastern Time, on February 4, 2025 — Crown's offer is the only fully-financed offer currently available toRevance's stockholders — Outside termination date under the […]